Effect of intravitreal anti-VEGF injection on choroidal thickness in patients with diabetic macula edema
AIM: To investigate for any detectable change in sub-foveal choroidal thickness following intravitreal injections of Ranibizumab or Aflibercept in patients with central involving diabetic macula edema(DME), evidenced by optical coherence tomography(OCT).METHODS: Totally 17 patients with central invo...
Main Authors: | Jia Cherng Chong, Hanizasurana Hashim, Tajunisah Iqbal |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2022-01-01
|
Series: | Guoji Yanke Zazhi |
Subjects: | |
Online Access: | http://ies.ijo.cn/cn_publish/2022/1/202201001.pdf |
Similar Items
-
CHOROIDAL THICKNESS IN PATIENTS WITH DIABETIC MACULAR EDEMA
by: Amash Aqil, et al.
Published: (2021-04-01) -
Subfoveal choroidal thickness in diabetic macular edema
by: Mohamed DM, et al.
Published: (2019-05-01) -
Factors Affecting a Short-Term Response to Anti-VEGF Therapy in Diabetic Macular Edema
by: Ayumi Usui-Ouchi, et al.
Published: (2021-01-01) -
A real-world study for timely assessing the diabetic macular edema refractory to intravitreal anti-VEGF treatment
by: Tsung-Cheng Hsieh, et al.
Published: (2023-05-01) -
Efficacy of single intravitreal injection of Ranibizumab for diabetic macular edema
by: Yu-Dong Fu, et al.
Published: (2017-03-01)